Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance
- 11 August 2011
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 137 (10) , 1525-1533
Abstract
Tumor-specific T regulatory cells (Treg) play a critical role in tumor cell survival. The development of tumor-specific Treg is not fully understood. This study aims to elucidate the role of matrix metalloproteinase (MMP)9 in tumor tolerance development.Keywords
This publication has 24 references indexed in Scilit:
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervixCellular & Molecular Immunology, 2010
- Regulatory T cells in tumor immunityInternational Journal of Cancer, 2010
- Perforin: structure, function, and role in human immunopathologyImmunological Reviews, 2010
- Tolerogenic dendritic cells and regulatory T cells: A two-way relationshipJournal of Dermatological Science, 2007
- Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivityImmunological Reviews, 2006
- The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunitySeminars in Immunology, 2006
- Transforming growth factor β (TGF-β) and autoimmunityAutoimmunity Reviews, 2005
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004